QS Batterymarch Financial Management’s WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS WX Stock Holding History

QS Batterymarch Financial Management’s Portfolio WX Stock Details WX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2014 Q3	$1.24M	Hold	35,400	–	–	0.03%	491
2014 Q2	$1.16M	Sell	35,400 -192,731	-84%	-$6.6M	0.03%	509
2014 Q1	$8.41M	Sell	228,131 -247,852	-52%	-$9.1M	0.17%	157
2013 Q4	$18.3M	Sell	475,983 -111,767	-19%	-$3.53M	0.39%	61
2013 Q3	$16.1M	Sell	587,750 -1,600	-0.3%	-$37.9K	0.35%	66
2013 Q2	$12.4M	Buy	+589,350	New	+$11.5M	0.24%	107

Other funds holding WX

Fidelity International Hamilton, Bermuda $129B AUM 30.83% 1-Year Est. Return

Schroder Investment Management Group London, United Kingdom $122B AUM 29.27% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

CWAM

Columbia Wanger Asset Management Chicago, Illinois $6.69B AUM 31.14% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

CBOA

Commonwealth Bank of Australia Sydney, NSW, Australia $231M AUM

Ninety One (UK) London, United Kingdom $44.7B AUM 17.24% 1-Year Est. Return

William Blair & Company Chicago, Illinois $34.9B AUM 18.88% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

QS Batterymarch Financial Management's WX Position: Q3 2014 in Review

QS Batterymarch Financial Management held its WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS (WX) position steady in Q3 2014 at 35,400 shares worth $1.24M. The position accounts for 0.03% of the portfolio, ranked #491.

QS Batterymarch Financial Management first reported a position in WX in Q2 2013 and has held it in 6 quarters since. The position peaked at $18.3M in Q4 2013. 157 funds tracked by Wall St. Rank hold WX as of Q3 2014.

QS Batterymarch Financial Management held 35,400 shares of WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS worth $1.24M as of Q3 2014.
QS Batterymarch Financial Management left its WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS share count unchanged in Q3 2014.
WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS made up 0.03% of QS Batterymarch Financial Management's portfolio in Q3 2014, its #491 holding.
QS Batterymarch Financial Management first reported a position in WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS in Q2 2013 and has held it in 6 quarters since.
QS Batterymarch Financial Management's WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS position peaked at $18.3M in Q4 2013.
157 funds tracked by Wall St. Rank held WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS as of Q3 2014.

Based on QS Batterymarch Financial Management's 13F filing for Q3 2014, filed 14 Nov 2014.